En Es
Products
Covid-19
Companies
Pre-Owned
News
Events
About Us       Join now!
Categories

Browse Products by Category

Critical Care

Emergency Medicine

Intensive Care

Respiratory Care

Anesthesiology Systems

Home Care

Rehabilitation

Other

Hospital Infrastructure

IT Equipment

Transportation Systems

Waste Management

Other

Medical Imaging

Computed Tomography

Digital Radiography

Image Management Systems

Interventional Radiology

Magnetic Resonance Imaging

Mammography

PACS/RIS

Positron Emission Tomography

Radiation Safety

Radiography

Single-Photon Emission Computed Tomography

Ultrasound

Other

Patient Care

Bariatric Care

Beds

Examination Equipment

Other

Surgery

Endoscopy

Laparoscopy

Laser Surgery

Operating Room Equipment

Sterilization

Surgical Implants

Surgical Instruments

Waste Management

Other

Expo: Clinical Laboratory

Blood & Blood Gas Analyzers

Cell Counters

Centrifuges

Clinical Chemistry Analyzer

Coagulation Analyzers

General Lab

Hematology Analyzers

Immunoassay Systems

Lab Glassware

Microplate Reader

Microscopes

Pipettes

Rapid Tests

Ready-to-use Kits for Analysis

Urine Analyzer

Point-Of-Care Testing

Browse Products by Category

Close

Luminex Corporation

Luminex Corporation

Luminex develops, manufactures, and markets biological testing technologies with applications in clinical diagnostics, pharmaceutical drug discovery, biomedical research, including genomic and proteomic research, personalized medicine, biodefense research, and food safety. The company’s open-architecture xMAP technolog ...
Products Covid-19NewsSummary
Close

Covid-19 Luminex Corporation

Clinical Laboratory

Multiplex Molecular Panel
ARIES Flu A/B & RSV+SARS‑CoV‑2 Assay (CE-IVD)

ARIES Flu A/B & RSV+SARS‑CoV‑2 is a multiplex, real-time, sample-to-answer PCR test utilized in the detection and differentiation of SARS‑CoV‑2, influenza A, influenza B, and RSV. The 2‑gene design (N and M genes) supports broad coverage of SARS‑CoV‑2 variants, while the built-in sample processing control confirms result validity.
More details

Respiratory Pathogen Panel + SARS-CoV-2
NxTAG Respiratory Pathogen Panel + SARS-CoV-2

The NxTAG Respiratory Pathogen Panel + SARS-CoV-2 (NxTAG RPP + SARS‑CoV‑2), developed for use on the NxTAG-Enabled MAGPIX® System, is a qualitative test for the detection of nucleic acids from multiple respiratory viruses and bacteria in nasopharyngeal swabs. The formulation of the assay is identical to NxTAG RPP, with the exception of the additional reagents required for the detection of SARS‑CoV‑2. No changes have been made to the existing NxTAG RPP reagents, reaction conditions, workflow, or software thresholds; therefore, the performance characteristics of NxTAG RPP are still applicable to NxTAG RPP + SARS‑CoV‑2.
More details

SARS-CoV-2 Test
NxTAG CoV Extended Panel

The NxTAG CoV Extended Panel offers SARS-CoV-2 detection using three viral genes (ORF1ab, E gene, and N gene), enabling accurate, reliable results. It is a highly scalable, cost-effective solution that can process up to 96 samples in approximately four hours and was developed for use on the MAGPIX NxTAG-enabled System. It has received Emergency Use Authorization (EUA) from the US FDA and Medical Device Authorization for Importation or Sale for Health Canada.
More details

SARS-CoV-2 Test
ARIES SARS-CoV-2 Assay

The ARIES SARS-CoV-2 Assay is a moderate-complexity, sample-to-answer test that detects SARS-CoV-2 in nasopharyngeal swabs. It allows for minimal hands-on time and an automated workflow deliver results in about two hours. Additionally, exonuclease-sensitive probes for the ORF1ab and N viral genes provide superior specificity.
More details

SARS-CoV2 Antibody Test
xMAP SARS-CoV-2 Multi-Antigen IgG Assay

The xMAP SARS-CoV-2 Multi-Antigen IgG Assay is a multiplex, microsphere-based, highly sensitive and specific assay that detects the presence or absence of antibodies against three different SARS-CoV-2 antigens. By using a combination of robust internal controls and highly-specific antigens, the assay may provide earlier, more sensitive results.
More details
Close

News of Luminex Corporation

DiaSorin’s Luminex Subsidiary to Spin Off Flow Cytometry Business to Cell Analysis Leader

15 Feb 2023
DiaSorin’s Luminex Subsidiary to Spin Off Flow Cytometry Business to Cell Analysis Leader
DiaSorin and Cytek Biosciences have announced that Luminex, a wholly owned subsidiary of DiaSorin, has signed an agreement with Cytek to sell substantially all of its assets related to the Flow Cytometry & Imaging (FCI) business unit.
Read More

DiaSorin Completes Acquisition of Luminex to Become a Full-Fledged Diagnostic and Life Science Player

16 Jul 2021
DiaSorin Completes Acquisition of Luminex to Become a Full-Fledged Diagnostic and Life Science Player
DiaSorin S.p.A. (?Saluggia?, Italy) has completed the acquisition of Luminex Corporation (Austin, TX, USA), allowing it to gain access to Luminex’s multiplexing technology and a portfolio that will strengthen its existing offering, while expanding the Group presence in the US.
Read More

DiaSorin to Acquire Luminex to Broaden Positioning in Molecular Diagnostics Space

13 Apr 2021
DiaSorin to Acquire Luminex to Broaden Positioning in Molecular Diagnostics Space
DiaSorin S.p.A. (?Saluggia?, Italy) has announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation (Austin, TX, USA) for approximately USD 1.8 billion.
Read More
Close

About Luminex Corporation

Luminex develops, manufactures, and markets biological testing technologies with applications in clinical diagnostics, pharmaceutical drug discovery, biomedical research, including genomic and proteomic research, personalized medicine, biodefense research, and food safety. The company’s open-architecture xMAP technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately.

Recently updated

Herpes Simplex Virus 1 & 2 Test
ARIES HSV 1&2 Assay

The ARIES HSV 1&2 Assay is a real-time polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection and differentiation of Herpes Simplex Virus 1 and 2 (HSV 1 and HSV 2) DNA in cutaneous or mucocutaneous lesion specimens from symptomatic patients. The test is indicated for use as an aid in the diagnosis of HSV infection in symptomatic patients and is meant for use on the ARIES System.
More details

Clostridium Difficile Nucleic Acid Test
VERIGENE Clostridium Difficile Test

The Verigene Clostridium difficile Nucleic Acid Test (CDF) is a qualitative, multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic strains Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI). The test is performed on the Verigene System and utilizes automated specimen preparation and polymerase chain reaction (PCR) amplification, combined with a nanoparticle-based array hybridization assay to detect the toxin gene sequences associated with toxin-producing C. difficile.
More details

Gastrointestinal Pathogen Panel
xTAG Gastrointestinal Pathogen Panel (GPP)

The xTAG Gastrointestinal Pathogen Panel (GPP) is a multiplexed nucleic acid test intended for the simultaneous qualitative detection and identification of multiple viral, parasitic, and bacterial nucleic acids in human stool specimens from individuals with signs and symptoms of infectious colitis or gastroenteritis. It can detect and identify >90% of the causative bacterial, viral, and parasitic agents of gastroenteritis, with fast, comprehensive results available in five hours.
More details

Clinical Laboratory

Herpes Simplex Virus 1 & 2 Test
ARIES HSV 1&2 Assay

The ARIES HSV 1&2 Assay is a real-time polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection and differentiation of Herpes Simplex Virus 1 and 2 (HSV 1 and HSV 2) DNA in cutaneous or mucocutaneous lesion specimens from symptomatic patients. The test is indicated for use as an aid in the diagnosis of HSV infection in symptomatic patients and is meant for use on the ARIES System.
More details

Clostridium Difficile Nucleic Acid Test
VERIGENE Clostridium Difficile Test

The Verigene Clostridium difficile Nucleic Acid Test (CDF) is a qualitative, multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic strains Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI). The test is performed on the Verigene System and utilizes automated specimen preparation and polymerase chain reaction (PCR) amplification, combined with a nanoparticle-based array hybridization assay to detect the toxin gene sequences associated with toxin-producing C. difficile.
More details

Gastrointestinal Pathogen Panel
xTAG Gastrointestinal Pathogen Panel (GPP)

The xTAG Gastrointestinal Pathogen Panel (GPP) is a multiplexed nucleic acid test intended for the simultaneous qualitative detection and identification of multiple viral, parasitic, and bacterial nucleic acids in human stool specimens from individuals with signs and symptoms of infectious colitis or gastroenteritis. It can detect and identify >90% of the causative bacterial, viral, and parasitic agents of gastroenteritis, with fast, comprehensive results available in five hours.
More details

Group B Streptococcus Test
ARIES GBS Assay

The ARIES GBS Assay detects Streptococcus agalactiae, also known as Group B Streptococcus (or GBS), from Lim broth-enriched vaginal-rectal specimen swabs obtained from pregnant women using the ARIES System. It enables labs to automate all aspects of testing - from sample preparation through analysis – and makes detecting antepartum GBS colonization in pregnant women accessible to labs of all sizes by using the sample-to-answer ARIES workflow.
More details

Enteric Pathogen Test
VERIGENE Enteric Pathogen Test

The VERIGENE Enteric Pathogen (EP) Test is a rapid, easy-to-use, and cost-effective alternative to traditional stool diagnostics that delivers clinical, economic, and workflow benefits to hospitals and laboratories. Confirmation of a negative stool sample takes only two hours on the VERIGENE System, allowing laboratories to reallocate technologist time to other priorities within the lab.
More details

Gastrointestinal Pathogen Panel
NxTAG Gastrointestinal Pathogen Panel

The NxTAG Gastrointestinal Pathogen Panel (GPP) is a multiplex PCR CE-IVD test that detects 16 bacterial, viral, and parasitic targets directly from human stool specimens alone or in Cary-Blair media from individuals with signs and symptoms of infectious colitis or gastroenteritis on an easy-to-use, single well, closed-tube system. As opposed to traditional workflows (which can take multiple days), NxTAG GPP delivers same-day results, including extraction and processing.
More details

C. difficile
ARIES C. difficile Assay

For patients suspected of having a CDI, the ARIES C. difficile Assay targets the C. difficile toxin A gene (tcdA) and toxin B gene (tcdB) with real-time PCR chemistry and is able to detect the presence of this bacterium from stool samples in just two hours. The assay is FDA Cleared and CE Marked for IVD use, and the simple, fully closed sample-to-answer system can be easily operated with minimal risk of contamination.
More details

Respiratory Pathogens Test
VERIGENE Respiratory Pathogens Flex Test

The VERIGENE Respiratory Pathogens Flex Test (RP Flex) is an automated, multiplexed, flexible nucleic acid test for the identification of the viruses and bacteria that most commonly cause respiratory infections. RP Flex is a single panel that addresses the full spectrum of respiratory testing needs in a cost-effective manner - one platform, one comprehensive panel, and finally, the flexibility to use and pay for only what you need.
More details

Multiplex Molecular Panel
ARIES Flu A/B & RSV+SARS‑CoV‑2 Assay (CE-IVD)

ARIES Flu A/B & RSV+SARS‑CoV‑2 is a multiplex, real-time, sample-to-answer PCR test utilized in the detection and differentiation of SARS‑CoV‑2, influenza A, influenza B, and RSV. The 2‑gene design (N and M genes) supports broad coverage of SARS‑CoV‑2 variants, while the built-in sample processing control confirms result validity.
More details

Imaging Flow Cytometer
Amnis ImageStream X Mk II

The Amnis ImageStreamX Mk II System is a benchtop, multispectral, imaging flow cytometer designed for the acquisition of up to 12 channels of cellular imagery. It combines the speed, sensitivity, and phenotyping abilities of flow cytometry with the detailed imagery and functional insights of microscopy to enable a broad range of applications.
More details

Flow Cytometer
Guava easyCyte

The Guava easyCyte Flow Cytometers are dynamic and flexible benchtop systems powered by intuitive software that provides greater sensitivity and optional high-throughput capabilities. The combination of microcapillary technology and a positive-displacement syringe pump allows for direct absolute counting with industry-leading precision.
More details

Methicillin-Resistant Staphylococcus Aureus (MRSA) Assay
ARIES MRSA Assay

The ARIES MRSA Assay aids in the prevention and control of Methicillin-resistant Staphylococcus aureus (MRSA), a Gram-positive bacteria that is resistant to several antibiotics, infections in healthcare settings. To increase the confidence in a MRSA call, the ARIES MRSA Assay includes mecA/mecC resistance gene detection, and SCCmec and orfX targets to ensure the resistance gene is associated with and present in S. aureus.
More details

Flow Cytometer
Amnis CellStream

The Amnis CellStream benchtop flow cytometry systems are highly-customizable, compact flow cytometers that use patented time delay integration charge-coupled device (TDI CCD) camera technology for detection, offering exceptional sensitivity for studying small particles. Combined with intuitive software and high-throughput acquisition, the systems allow users to resolve complex cell populations and view cells as they are analyzed in real time—making quality control and obtaining consistent results easier than ever.
More details

Cell Analyzer
Guava Muse Cell Analyzer

The Guava Muse Cell Analyzer packs 3-parameter analysis into a compact, easy to use benchtop device, making flow cytometry accessible to anyone, anytime. The Muse Instrument has an integrated touchscreen and software for data acquisition and analysis using optimized Muse Assays. Its microcapillary flow cell is engineered for acquisition of both suspension and adherent cells 2-60 microns in diameter.
More details

Respiratory Pathogen Panel + SARS-CoV-2
NxTAG Respiratory Pathogen Panel + SARS-CoV-2

The NxTAG Respiratory Pathogen Panel + SARS-CoV-2 (NxTAG RPP + SARS‑CoV‑2), developed for use on the NxTAG-Enabled MAGPIX® System, is a qualitative test for the detection of nucleic acids from multiple respiratory viruses and bacteria in nasopharyngeal swabs. The formulation of the assay is identical to NxTAG RPP, with the exception of the additional reagents required for the detection of SARS‑CoV‑2. No changes have been made to the existing NxTAG RPP reagents, reaction conditions, workflow, or software thresholds; therefore, the performance characteristics of NxTAG RPP are still applicable to NxTAG RPP + SARS‑CoV‑2.
More details

SARS-CoV2 Antibody Test
xMAP SARS-CoV-2 Multi-Antigen IgG Assay

The xMAP SARS-CoV-2 Multi-Antigen IgG Assay is a multiplex, microsphere-based, highly sensitive and specific assay that detects the presence or absence of antibodies against three different SARS-CoV-2 antigens. By using a combination of robust internal controls and highly-specific antigens, the assay may provide earlier, more sensitive results.
More details

SARS-CoV-2 Test
ARIES SARS-CoV-2 Assay

The ARIES SARS-CoV-2 Assay is a moderate-complexity, sample-to-answer test that detects SARS-CoV-2 in nasopharyngeal swabs. It allows for minimal hands-on time and an automated workflow deliver results in about two hours. Additionally, exonuclease-sensitive probes for the ORF1ab and N viral genes provide superior specificity.
More details

SARS-CoV-2 Test
NxTAG CoV Extended Panel

The NxTAG CoV Extended Panel offers SARS-CoV-2 detection using three viral genes (ORF1ab, E gene, and N gene), enabling accurate, reliable results. It is a highly scalable, cost-effective solution that can process up to 96 samples in approximately four hours and was developed for use on the MAGPIX NxTAG-enabled System. It has received Emergency Use Authorization (EUA) from the US FDA and Medical Device Authorization for Importation or Sale for Health Canada.
More details

BC-GN Test
VERIGENE BC-GN Test

The VERIGENE BC-GN Test identifies genus, species, and genetic resistance determinants for a broad panel of gram-negative bacteria directly from positive blood culture bottles. It provides results within two hours of blood culture positivity, reducing time to patient therapy and increasing cost savings.
More details

BC-GP Test
VERIGENE BC-GP Test

The VERIGENE BC-GP Test identifies genus, species, and genetic resistance determinants for a broad panel of gram-positive bacteria directly from positive blood culture bottles. It provides results within 2.5 hours of blood culture positivity, reducing time to patient therapy and increasing cost savings.
More details

Molecular Diagnostics Workstation
VERIGENE System

The VERIGENE System is a workstation for molecular diagnostics that utilizes advanced automation and proprietary chemistry to enable rapid, sample to result detection of nucleic acid and protein targets. It offers automated, cost-effective multiplex capabilities that rapidly and accurately detect infectious pathogens and drug resistance markers, without relying on time-consuming culture methods.
More details

Multiplex Reader
Luminex 200

The Luminex 200 multiplex reader is a clinical diagnostics instrument that allows multiplexing of up to 100 analytes in a single well of a microtiter plate, using very small samples. It delivers fast and cost-effective bioassay results on many assay formats including nucleic acid assays, receptor-ligand assays, immunoassays, and enzymatic assays.
More details

Multiplex Reader
MAGPIX

The MAGPIX is a compact multiplex reader that can perform up to 50 different tests in a single reaction volume and read a 96-well-plate in 60 minutes. It features self-cleaning routines and magnetic bead compatibility, making the instrument easy to learn and easy to use.
More details

Molecular Diagnostic Test
ARIES Flu A/B & RSV

The ARIES Flu A/B & RSV assay is for the detection/differentiation of influenza A&B, and RSV from nasopharyngeal swabs. It features integrated sample processing control to ensure the assay run is successful from extraction through amplification with results delivered in less than two hours.
More details

Flow Cytometry Analyzer
Luminex 200

The Luminex 200 is a flow cytometry analyzer which allows for simultaneously measurement of up to 100 analytes in a single microplate well, using very small samples, and includes an analyzer, plate handling platform, sheath fluid delivery system, software, and PC. It delivers fast and cost-effective bioassay results on many assay formats, including nucleic acid assays, receptor-ligand assays, immunoassays, and enzymatic assays.
More details

Immunoassay System
FLEXMAP 3D

The FLEXMAP 3D is a multiplexing platform with fast read time, compatibility with both 96- and 384-well plates, and ease of integration with front-end automation systems. It uses both magnetic and non-magnetic microspheres and can simultaneously measure up to 500 genes or proteins from a small sample, making it ideal for high throughput applications.
More details

In Vitro Diagnostic System
ARIES M1

The ARIES M1 is a fully integrated, sample to answer platform for performing real-time PCR assays with features such as an intuitive system interface, STAT or batch testing, and true walkaway capability. It extracts, amplifies and detects nucleic acid targets from a variety of sample types, and can process up to six different samples, and one to six assays, at a time, making it ideal for lower throughput clinical labs.
More details
Copyright © 2000-2024 TradeMed.com. All rights reserved. | Terms And Conditions